Back
Abits Group, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
29
ABTS
Abits Group, Inc.
Last Price:
$6.06
Seasonality Move:
-4.69%
Sell
39
MNPR
Monopar Therapeutics, Inc.
Last Price:
$74.46
Seasonality Move:
36.18%
Sell
29
Abits Group, Inc. (ABTS)
is a Sell
Is Abits Group, Inc. a Buy, Sell or Hold?
-
The current Abits Group, Inc. [ABTS] share price is $5.78. The Score for ABTS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
ABTS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $74.61. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABTS Stock Price Chart
What is Abits Group, Inc.'s stock price today?
-
The Abits Group, Inc. share price today is $5.78Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABTS is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $74.61Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
ABTS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 45.77 | Sell |
| Chaikin Money Flow: | -1943 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.71 - 6.31) | Sell |
| Bollinger Bands (100): | (4.05 - 7.75) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.71 | Sell |
| Relative Strength Index (14 RSI): | 41.23 | Sell |
| Chaikin Money Flow: | -100149 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (76.75 - 86.63) | Sell |
| Bollinger Bands (100): | (43.73 - 88.49) | Buy |
ABTS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.06 | Sell |
| 20-day SMA: | 5.97 | Sell |
| 50-day SMA: | 6.79 | Sell |
| 200-day SMA: | 4.79 | Buy |
| 8-day EMA: | 6.02 | Sell |
| 20-day EMA: | 6.09 | Sell |
| 50-day EMA: | 6.27 | Sell |
| 200-day EMA: | 5.91 | Sell |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.35 | Sell |
| 20-day SMA: | 81.26 | Sell |
| 50-day SMA: | 84.43 | Sell |
| 200-day SMA: | 51.38 | Buy |
| 8-day EMA: | 77.66 | Sell |
| 20-day EMA: | 80.1 | Sell |
| 50-day EMA: | 78.38 | Sell |
| 200-day EMA: | 56.01 | Buy |
Abits Group, Inc. Earnings Growth & ABTS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Abits Group, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||